Robert Wayne Baker, NP

Robert Baker practices at L.A. Downtown Medical Center in Los Angeles, California, part of Downtown Medical Center.

Robert Baker's NPI, 1689225427, was assigned on September 23, 2019. Robert Baker holds California license 95012875.

Robert Baker's primary practice is L.A. Downtown Medical Center, at 1711 West Temple Street, Los Angeles, CA 90026 in Los Angeles County. The practice phone is (213) 989-6123.

Robert Baker's primary practice is L.A. Downtown Medical Center in Los Angeles, California, part of Downtown Medical Center. The medical group on file is Foothill Pulmonary and Critical Care Consultants Medical Group, Inc. Dmand AI also links Robert Baker to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Robert Baker practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatric/mental health is Robert Baker's primary specialty in the NPI Registry, under taxonomy code 363LP0808X. Robert Baker is licensed in California.

Dmand AI lists anxiety, bipolar disorder, chronic diabetes, depression, insomnia, intellectual and developmental disabilities, non-alzheimer's dementia (chronic) and schizophrenia among the conditions Robert Baker treats.

CMS data shows 10,504 Medicare services from Robert Baker across 12 procedure codes in 2024, for 1,379 Medicare patients. Medicare paid $517,886 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,379 Medicare patients who saw Robert Baker in 2024. The largest group is 65 to 74, with 536 patients. 75% of them have anxiety, and 75% have arthritis. 90% are also on Medicaid. Their average risk score is 3.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Robert Baker's median patient age at 72, with 49% women.

In 2024, Robert Baker wrote 1,233 Medicare Part D claims for 209 patients. 66% of them were for generic drugs. CMS names the drug for 1,105 of them, across 18 drugs with 11 or more claims each, at $1,509,084 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Robert Baker for performance year 2024, reported as part of a group. Robert Baker accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 73 general payments to Robert Baker from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $1,125.